GSK plc ADRhedged
Price through Nov 13, 2026 · Flows through unavailable. Figures use the latest available records, not a live quote. Fund details retrieved Nov 13, 2026. Holdings snapshot retrieved Nov 13, 2026.
Under typical conditions, this investment vehicle commits a predominant portion—no less than 95%—of its total assets to American Depositary Receipts (ADRs) representing GSK plc. It notably avoids direct investment in the company's underlying shares. Such a focused approach means the fund operates as a non-diversified portfolio.
GSKH price
Table
| Date | GSKH close |
|---|---|
| Oct 13, 2026 | $65.79 |
| Oct 14, 2026 | $68.35 |
| Oct 15, 2026 | $69.55 |
| Oct 16, 2026 | $69.87 |
| Oct 19, 2026 | $69.86 |
| Oct 20, 2026 | $71.11 |
| Oct 21, 2026 | $70.39 |
| Oct 22, 2026 | $71.86 |
| Oct 23, 2026 | $71.37 |
| Oct 26, 2026 | $71.94 |
| Oct 27, 2026 | $71.96 |
| Oct 28, 2026 | $68.79 |
| Oct 29, 2026 | $68.45 |
| Oct 30, 2026 | $69.49 |
| Nov 2, 2026 | $68.95 |
| Nov 3, 2026 | $68.34 |
| Nov 4, 2026 | $71.28 |
| Nov 5, 2026 | $70.46 |
| Nov 6, 2026 | $70.91 |
| Nov 9, 2026 | $71.98 |
| Nov 10, 2026 | $72.30 |
| Nov 11, 2026 | $71.78 |
| Nov 12, 2026 | $71.95 |
| Nov 13, 2026 | $72.64 |
Recent fund-flow records are unavailable, while the price has returned +6.5% so far this year. At 0.17% a year it is not the cheapest way in — XLV has a reported fee of 0.08%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | GSKGSK | 96.57% | $50.45 | -0.4% | ||
| 2 | —Cash (US$) | 3.43% | — | — | — |
| 1 week | +0.5% |
| 1 month | +4.0% |
| 3 months | +5.4% |
| 6 months | +2.7% |
| YTD | +6.5% |
| 1 year | +6.8% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | — |
| 1 month | — |
| 3 months | — |
| YTD | — |
| 1 year | — |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The top holding is 96.6% of the book; the top ten carry 100%. Spread across 2+ names, it behaves like roughly 1 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| GSK GSK | $267,455 | $76,841 |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat GSKH on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| LGLV State Street SPDR US Large Cap Low Volatility Index ETF | 0.12% | $1.1B | +$20M | -5bp on fee · 1419× the assets · +$20M in over the month | Head-to-head |
| USMV iShares MSCI USA Min Vol Factor ETF | 0.15% | $24.5B | +$35M | -2bp on fee · 31227× the assets · +$35M in over the month | Head-to-head |
| BUFR FT CBOE VEST FUND OF BUFFER ETFS | 0.10% | $5.1B | — | -7bp on fee · 6458× the assets | Head-to-head |
| FDLO Fidelity Low Volatility Factor ETF | 0.15% | $1.2B | — | -2bp on fee · 1565× the assets | Head-to-head |
| ACWV iShares MSCI Global Min Vol Factor ETF | 0.20% | $3.3B | +$113K | 4218× the assets · +$113K in over the month | Head-to-head |